Get started
GRANULES INDIA LTD.GRANULES INDIA LTD.GRANULES INDIA LTD.

GRANULES INDIA LTD.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

GRANULES trade ideas

Granules india ltd### **Comprehensive Analysis of Granules India Ltd (NSE: GRANULES)** #### **1. Fundamental Analysis:** **Overview:** Granules India Ltd is a leading pharmaceutical manufacturer based in India, engaged in the production of active pharmaceutical ingredients (APIs), pharmaceutical formulations, and drug intermediates. The company is known for its strong presence in the global pharmaceutical market and has a diverse product portfolio across various therapeutic segments, including pain management, cardiovascular diseases, and anti-diabetics. **Key Financials (as of latest available data):** - **Market Capitalization**: ₹16,330 crore (as of Feb 2025) - **Revenue Growth**: Granules India has shown consistent growth in revenue driven by the rising demand for generic drugs, expansion in the U.S. and European markets, and solid growth in both domestic and international markets. - **Profitability**: The company has demonstrated strong profitability margins with a stable net profit margin in recent quarters. Granules India’s focus on high-value APIs and formulations allows for higher margins. - **Debt Levels**: Granules has a relatively low debt-to-equity ratio, which is favorable for its financial stability. The company has been successful in reducing debt over the years, contributing to its ability to generate strong cash flow. **Recent Developments:** - **Acquisitions and Expansion**: Granules India continues to expand its manufacturing capacity and distribution networks, particularly in the U.S. and European markets. The company has also ramped up its research and development (R&D) activities, focusing on complex generics. - **Regulatory Approvals**: Granules India has received multiple approvals from the U.S. FDA for manufacturing formulations and APIs, which has contributed to the growth in exports. **Key Strengths:** - Strong portfolio of APIs and formulations, with a significant presence in global markets. - Diversified customer base, including leading pharmaceutical companies. - Consistent focus on R&D and expanding its product offerings. - Robust balance sheet with low debt. **Risks:** - **Regulatory Risks**: The pharmaceutical industry is heavily regulated, and any regulatory setbacks (e.g., delays in approvals or compliance issues) could impact operations, especially in international markets like the U.S. and Europe. - **Competition**: Granules faces significant competition in the generic drug market, particularly from larger multinational pharmaceutical companies. - **Currency Fluctuations**: Being an export-oriented company, Granules India is exposed to foreign exchange risks, especially as the majority of its revenue comes from the U.S. and European markets. --- #### **2. Technical Analysis:** **Current Price Action (as of February 2025):** - **Stock Price**: ₹306 (as of Feb 2025) - **52-week High/Low**: ₹415 (High) – ₹292 (Low) - **Recent Trend**: Granules India has experienced some volatility over the past year, with a noticeable downward correction after hitting its 52-week high. The stock has been in a consolidation phase recently, with support forming around the ₹300 mark. **Moving Averages:** - **50-Day Moving Average (50-DMA)**: ₹308 - **200-Day Moving Average (200-DMA)**: ₹356 - Currently, Granules is trading below both the 50-DMA and 200-DMA, which suggests a bearish trend in the short-to-medium term. The stock has been testing the 50-DMA as resistance in the recent past. **Relative Strength Index (RSI):** - RSI is at **41**, which indicates that the stock is not in the overbought territory but is leaning toward the oversold zone. This suggests the stock could be a potential buy if it starts to show signs of stabilization and reversal. **MACD (Moving Average Convergence Divergence):** - The MACD line is currently below the signal line, which points to a bearish signal. If the MACD crosses above the signal line, it could be an indication of a reversal toward bullish momentum. **Volume Analysis:** - The volume is showing signs of increasing during price corrections, which suggests that there is interest in buying the stock at lower levels. A spike in volume during an upward breakout could confirm a potential price rally. --- #### **3. Support and Resistance Levels:** **Support Levels:** - **₹290-300**: This range has acted as strong support during recent corrections. A breach of this support could indicate further downside potential. - **₹275**: This level is another key support to watch if the stock breaks below the ₹300 level. A bounce off ₹275 would be an encouraging sign for bulls. **Resistance Levels:** - **₹320**: The immediate resistance for the stock is around ₹320. If the stock manages to cross this level and sustain it, it could trigger an upward momentum. - **₹350-360**: The stock faces stronger resistance in the range of ₹350-360, which corresponds to the 200-DMA. A break above this resistance could signal a trend reversal. **Key Levels to Watch for Short-Term Movement:** - **Immediate Resistance**: ₹320 (50-DMA) - **Immediate Support**: ₹290 (recent low) --- #### **4. Risk and Reward Outlook:** **Risk Factors:** - **Regulatory Risks**: As Granules India depends on regulatory approvals for its products, delays or rejections could impact revenue generation, especially in international markets like the U.S. - **Market Volatility**: The pharmaceutical sector is subject to government pricing pressures and regulatory risks, which could affect profitability. - **Currency Risks**: Granules is exposed to currency fluctuations since a significant portion of its revenue comes from exports, primarily to the U.S. and Europe. **Reward Potential:** - The stock offers a good upside potential in the medium-to-long term if the global demand for generics and APIs continues to rise. - Granules has a solid financial base, low debt, and a diverse product range, which bodes well for future growth, especially if it can scale up its R&D efforts. --- #### **5. Investment Recommendation:** - **Long-Term Investors**: Granules India offers a promising growth story due to its strong presence in the generic drug market and its expanding global footprint. Investors who are looking for exposure to the pharmaceutical sector could consider buying the stock at current levels, especially if it reaches the support range of ₹290-300. - **Short-Term Traders**: For traders, it's advisable to wait for a breakout above ₹320 for confirmation of upward momentum. A breakdown below ₹290 could trigger a further decline in the stock. --- ### **Disclaimer:** The information and analysis presented here are for educational and informational purposes only. We are not registered with SEBI (Securities and Exchange Board of India) or any other regulatory body, and this should not be construed as investment advice. Stock market investments are subject to market risks, and past performance is not indicative of future results. Before making any investment decisions, it is important to conduct thorough research, seek advice from a certified financial advisor, and understand your risk tolerance. The views expressed are based on publicly available data and personal analysis, and may not necessarily reflect the views of other professionals or organizations.
NSE:GRANULESLong
by Globaltradehub
Granules India for 35%+ gainsDate: 3 Oct’24 Stock: Granules Timeframe: Daily chart Granules India seems to have begun its up move in Wave V of 5 which could end around 810-820 (>35% from current price of 595) as seen in the chart. High volumes and strong reversal of RSI supports this stance. This is not a trade recommendation. Please do your own analysis. Aisa lagata hai ki Granules India ne 5 ke Wave V mein apni badhat shuroo kar dee hai, jo 810-820 (595 kee vartamaan keemat se 35%) ke aasapaas samaapt ho sakatee hai, jaisa ki chart mein dekh sakte hain. Achhi volume aur RSI ka majaboot ulataav is rukh ka samarthan karta hai. Yeh koi vyaapaar ki rai nahin hai. Kripya apna vishleshan khud karein.
NSE:GRANULESLong
by DhandhaPaani
2
GRANULES INDIA LTDBuy above 595 All important points are marked. 𝐃𝐢𝐬𝐜𝐥𝐚𝐢𝐦𝐞𝐫: 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐢𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞 𝐬𝐮𝐛𝐣𝐞𝐜𝐭 𝐭𝐨 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐢𝐬𝐤𝐬, 𝐫𝐞𝐚𝐝 𝐚𝐥𝐥 𝐭𝐡𝐞 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐝𝐨𝐜𝐮𝐦𝐞𝐧𝐭𝐬 𝐜𝐚𝐫𝐞𝐟𝐮𝐥𝐥𝐲 𝐛𝐞𝐟𝐨𝐫𝐞 𝐢𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠. 𝐒𝐭𝐨𝐜𝐤𝐬 𝐬𝐮𝐠𝐠𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐠𝐫𝐨𝐮𝐩 𝐚𝐫𝐞 𝐟𝐨𝐫 𝐞𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧 𝐩𝐮𝐫𝐩𝐨𝐬𝐞. 𝐖𝐞 𝐝𝐨𝐧𝐭 𝐦𝐚𝐤𝐞 𝐚𝐧𝐲 𝐩𝐫𝐨𝐟𝐢𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐢𝐬 𝐫𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐚𝐭𝐢𝐨𝐧𝐬 𝐞𝐯𝐞𝐫𝐲𝐭𝐡𝐢𝐧𝐠 𝐬𝐡𝐚𝐫𝐞𝐝 𝐡𝐞𝐫𝐞 𝐚𝐫𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞𝐥𝐲 𝐨𝐟 𝐟𝐫𝐞𝐞 𝐨𝐟 𝐜𝐨𝐬𝐭.
NSE:GRANULESLong
by sreekumars
GRANULES READY TO FIRE The “W” chart pattern, also known as the double bottom pattern, is a bullish reversal pattern in technical analysis. It indicates a potential change from a bearish trend to a bullish trend. Here’s a brief overview: Characteristics of the W Pattern: Formation: The pattern forms after a downtrend and consists of two consecutive lows (bottoms) with a peak in between, creating a “W” shape on the chart12. Support Levels: The two bottoms represent significant support levels. The price drops to a certain level, rebounds, drops again to a similar level, and then rebounds once more1. Breakout: The pattern is confirmed when the price breaks above the peak between the two bottoms. This breakout signals a potential upward trend2. How to Trade the W Pattern: Entry Point: Traders often enter a long position when the price breaks above the peak between the two bottoms. Stop Loss: A stop loss is typically placed below the second bottom to manage risk. Profit Target: The profit target can be estimated by measuring the distance between the bottoms and the peak, and projecting that distance upward from the breakout point
NSE:GRANULESLong
by Faizgazi
A rally to exitGranules CMP 540 Elliott- These sharp falls are just the first leg A of the three wave correction ABC. The stock should rally from around this zone to 647. In my view exit this counter on this rally. Coz the devastating C leg will start from here. Which should complete around the 380 zone. This place will be an opportunity to buy. Pattern - this is an inverted V shape fall and is a directional signal. Volume- that bear candle has huge volume. This means bears are in total control. Conclusion - the bears will leave it a bit loose. And its the retail that will be caught in this rally .So do not fall for it. Use the rally to exit your longs. Traders that C leg will be a hell of an opportunity.
NSE:GRANULES
by singh17vivek
Granuels Date 15.09.2024 Granuels Timeframe : Weekly Q : Why stock fell so much ? Ans : Granules India had a huge fall on September 12 after the USFDA inspection revealed 6 observations. Q : What does Granules company do ? Ans : Granules is an Indian multinational pharmaceutical manufacturing company based in Hyderabad. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin, Guaifenesin etc Remarks : 1 If breaks low then don't try to catch the falling knife rather one can go short & trail. 2 If crosses Ichimoku's base line then go long & keep last week low as a stop-loss. 3 There's huge divergence in option data as well & large unwinding of orders. 4 Current PCR is at 0.50 which quite oversold, hence expected to bounce from here Regards, Ankur
NSE:GRANULESLong
by AnkurSingh